Main Page Article Search E-Lerts™ Newsletter: Current E-Lerts™ Newsletter Archives E-Lerts™ Newsletter Recipes Archives Defeat Diabetes® E-Lerts™ Newsletter Subscribe Defeat Diabetes ® News by Daniel H. Rasolt Books You Can Use™ Subscribe to Defeat Diabetes Foundation Mailings
About Diabetes Body Care Children Complications Defeat Diabetes Foundation Drugs Elderly E-Lerts™ Governments & Organizations Health & Fitness Insulin MADDCAP™ Mr. Diabetes® Nutrition Obesity Other Diseases Pregnancy Research Risks Self-Management Supplements Type 1 Warning Signs

 

 

 

     

Search our News Articles Archives for diabetes and health news. Search by word or phrase.  The latest article will appear first.

Search For:  

Search in all categories / subcategories
Search in current category / subcategory

Efficacy and Safety of Bydureon Versus Metformin, Pioglitazone, and Sitagliptin as Monotherapy Posted: Monday, February 06, 2012

In a once weekly injection of exenatide for Drug-Naive Patients with Type 2 Diabetes (DURATION-4) in a 26-week double-blind study they found that exenatide once weekly (EQW) was noninferior to metformin (MET) but not pioglitazone (PIO) and superior to sitagliptin (SITA) with regard to HbA1c reduction at 26 weeks.

Gene Study Sheds Light on Body Clock's Link to Diabetes Posted: Monday, February 06, 2012

A mutation affecting a sleep-wake hormone may disrupt blood sugar control.

Metformin May Help Protect Women against Pancreatic Cancer Posted: Sunday, February 05, 2012

A new study links the diabetes drug metformin to fewer cases of pancreatic cancer -- at least in women -- but finds other diabetes medications are associated with a higher risk of the disease.

Stem Cell Therapy May Reverse Diabetes Posted: Sunday, January 29, 2012

An immune regulator from healthy cord blood stem cells (CB-SCs) can "educate" the T cells of a person with type 1 diabetes, enabling the pancreas to produce insulin.

FDA Approves BYDUREON™ -- The First Once-Weekly Treatment for Type 2 Diabetes Posted: Sunday, January 29, 2012

Once weekly Bydureon will be available in February at the approximate coast of $323 dollars a month which will include 4 injection syringes using 1 per week.

Diabetes Affects Hearing Loss Posted: Sunday, January 29, 2012

Having diabetes may cause women to experience a greater degree of hearing loss as they age, especially if the metabolic disorder is not well controlled with medication.

New Information on Link between 'Killer Cells' and Diabetes Posted: Saturday, January 28, 2012

Our own killer T-cells in the human body which help protect us from disease may inadvertently destroy cells that produce insulin.

Intranasal Insulin Boosts Cognitive Function Posted: Saturday, January 28, 2012

Pooled data suggest that intranasal insulin may have a positive effect on cognition in both impaired and normal subjects.

New NIH fact sheet explains test for diabetes, prediabetes Posted: Thursday, January 26, 2012

A new fact sheet from the National Institutes of Health explains the A1C test, a widely used and important test to diagnose type 2 diabetes and prediabetes, and to monitor blood glucose levels of people with type 1 and type 2 diabetes.

Flavonoids Helps to Prevent Heart Disease in Type 2 Diabetic Women Posted: Monday, January 23, 2012

Dietary flavonoids found in foods such as berries and chocolate may reduce the risk of women with type 2 diabetes developing heart disease.

 

 

 

 

 

 Costa Rica Travel Corp. will donate a portion of the proceeds to and is a sponsor of Defeat Diabetes Foundation.